Recently, we, and others, have uncovered that high‐risk MYCN‐amplified neuroblastomas are characterized by a striking GPX4 dependency (Floros et al, 2021; Lu et al, 2021; Alborzinia et al, 2022). This evidence concerns the gene GPX4 and neuroblastoma.